Remedy Pharmaceuticals Releases Its 2016 Year-In-Review Report

Via: LinkedIn

Remedy Pharmaceuticals, a privately-held, clinical stage pharmaceutical company focused on developing and bringing lifesaving treatments to people affected by acute central nervous system (CNS) edema, has released its 2016 year-in-review report.

Read More: http://www.remedypharmaceuticals.com/uploads/7/1/7/3/71731607/remedy2016report.pdf